PharmaCyte Biotech Inc [PMCB]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 20.52% | 18.28% | 11.79% |
| Loss % | -17.42% | -18.35% | 6.09% |
| Duration | 9.0d | 8d | 5.3d |
| Total Pivots Found | 8 |
| Gain/Loss Legs | 7 (4 Gain / 3 Loss) |
| Last Pivot | Top @ $0.76 on 2026-06-12 |
| Change since Last Pivot | $0.00 (0.00%) |
Next Pivot Prediction Last: $0.76
| Predicted Next Type | Bottom |
| Predicted Price (Avg) | $0.63 |
| Predicted Price (Median) | $0.62 |
| Predicted Price Range (~68%) | $0.58 - $0.67 |
| Change to Avg Target | $-0.13 (-17.42%) |
| Predicted Date (Avg) | 2026-06-21 |
| Predicted Date Range (~68%) | 2026-06-15 - 2026-06-26 |
| Basis | Based on 3 historical losses (Avg: -17.42%, Median: -18.35%, StdDev of Abs: 6.09%) and duration (Avg: 9.0 days, StdDev: 5.3 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
PharmaCyte Biotech Inc gained modestly, up 1.45%.
PharmaCyte Biotech Inc (PMCB) stock price advanced on Friday after the stock rose $0.0109 (1.45%) from the previous session on above-average volume. The stock moderately outperformed the market today, rising faster than the NASDAQ's 0.31% gain. A total of 170 292 stocks were traded yesterday, valued at $129 592, 20 728 shares less than the previous day (191 020 shares traded). This is above the average volume for the stock at 122 686 shares traded per day.
PharmaCyte Biotech Inc signals
There is no conclusive signals given from RSI. The price is above the short-term average yet below the long-term average, with the short-term average still below the long-term average; signals are mixed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-20%), medium- (-20%), and long-term (-20%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
PharmaCyte Biotech Inc Support & Resistance Levels
The stock is trading above the closest support level at $0.710. approximately $0.0510 (6.70%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s10.71 -
PharmaCyte Biotech Inc Evaluation
- Short score: -1.22
- Medium score: -2.21
- Long score: -2.50